Market Trends of Fractional Flow Reserve Industry
This section covers the major market trends shaping the Fractional Flow Reserve Market according to our research experts:
Guidewires Segment is Expected to Hold a Major Market Share in the Fractional Flow Reserve Market
The guidewires segment is expected to grow significantly over the forecast period. Pressure guidewires are used in procedures to determine if any surgery is required in the vessels or arteries of the heart. It also acts as a navigator's tool to reach the lesion. The growing popularity of angiography and its unique characteristics are expected to have a positive influence on this market segment.
The increase in the number of cardiac-related surgeries that require the use of guidewires is expected to boost the growth of the studied segment over the forecast period. For instance, as per the OECD statistics published in November 2022, around 11,029 transluminal coronary angioplasty surgeries were performed in Norway in the year 2021, and nearly 10,330 procedures were performed in Portugal. Thus, the large number of angioplasty procedures is expected to increase the demand for guidewires, which in turn is expected to propel the growth of the market segment over the forecast period.
Moreover, the recent studies focusing on the improvement of existing guidewires are expected to contribute to the growth of the studied segment over the forecast period. For example, a research study by a group of researchers from Egypt examined guidewire insertion in the fractional flow reserve. This study was published by Biomedical Engineering Online in September 2021 and offered a solution to reduce the errors caused by the insertion of fractional flow reserve guidewire. Hence, the rise in research studies focusing on the utilization of guidewires in fractional flow reserves is likely to add to the growth of the guidewires segment over the forecast period.
Several key market players have also played a major role in the growth of the studied segment. For instance, in October 2021, Baylis Medical Company Inc. was acquired by Boston Scientific Corporation for an upfront payment of USD 1.75 billion. The purpose of the acquisition was to increase Boston Scientific's structural heart and electrophysiology product portfolios by bringing in radiofrequency (RF) NRG and VersaCross transseptal platforms. Furthermore, the agreement will help the company acquire a variety of dilators, guidewires, and sheaths for improving healthcare efficiency.
Thus, the guidewires segment is expected to hold a significant market share during the forecast period.
North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period
North America is expected to hold a major market share in the fractional flow reserve market due to the increasing geriatric population linked with cardiovascular diseases and growing technological advancements in FFR monitoring devices.
A large number of people in the region are affected by heart diseases, which is a major factor contributing to the market's growth over the forecast period. For instance, according to the CDC data updated in July 2022, coronary heart disease is the most common type of heart disease, and approximately 20.1 million adults age 20 and older have the disease in the United States. Additionally, as per the same source, every 40 seconds, one individual suffers from a heart attack, and nearly 805,000 people in the United States have a heart attack every year. According to the AHA, by 2035, around 45% of the United States population is likely to suffer from heart disease due to factors like high obesity, high smoking, and unhealthy lifestyles, which may lead to heart attacks and other related issues. The fractional flow reserve method is the most commonly used invasive standard for identifying stenosis in the coronary artery, and the large population affected by heart diseases in the region is likely to add to the growth of the fractional flow reserve market over the forecast period.
Furthermore, as per the study published in IJERPH in January 2022, the geriatric population is more susceptible to developing cardiovascular disease owing to the impairment of the optimal functionality of the cardiovascular system caused by aging. Also, the geriatric population in the United States has been increasing over the years. The number of people over the age of 65 in the United States is projected to reach 80.8 million by the year 2040, and the numbers are projected to rise to 94.7 million by the year 2060, according to the Administration for Community Living, May 2021. The number of people over the age of 85 is projected to be 14.4 million by the year 2040, increasing the demand for FFR products.
Additionally, in July 2021, one of the key players in the FFR market, HeartFlow, announced a merger with Longview Acquisition Corp. II in order to become a publicly traded company. When the proposed deal is completed, the merged company will conduct business as HeartFlow Group Inc. Thus, these aforementioned factors are altogether contributing to the growth of the market in the North American region.
